Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Payables (2018 - 2025)

Historic Payables for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $8.7 million.

  • Viemed Healthcare's Payables rose 4433.16% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 4433.16%. This contributed to the annual value of $5.3 million for FY2024, which is 2732.06% up from last year.
  • Per Viemed Healthcare's latest filing, its Payables stood at $8.7 million for Q3 2025, which was up 4433.16% from $8.3 million recorded in Q2 2025.
  • Over the past 5 years, Viemed Healthcare's Payables peaked at $8.7 million during Q3 2025, and registered a low of $2.5 million during Q2 2021.
  • For the 5-year period, Viemed Healthcare's Payables averaged around $5.0 million, with its median value being $4.7 million (2021).
  • Per our database at Business Quant, Viemed Healthcare's Payables plummeted by 6028.21% in 2021 and then surged by 6658.56% in 2023.
  • Over the past 5 years, Viemed Healthcare's Payables (Quarter) stood at $3.2 million in 2021, then fell by 18.18% to $2.6 million in 2022, then surged by 57.74% to $4.2 million in 2023, then grew by 27.32% to $5.3 million in 2024, then skyrocketed by 62.91% to $8.7 million in 2025.
  • Its Payables was $8.7 million in Q3 2025, compared to $8.3 million in Q2 2025 and $7.9 million in Q1 2025.